E-cadherin expression is associated with somatostatin analogue response in acromegaly
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
E-cadherin expression is associated with somatostatin analogue response in acromegaly
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-03-07
DOI
10.1111/jcmm.13851
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MANAGEMENT OF ENDOCRINE DISEASE: Personalized medicine in the treatment of acromegaly
- (2018) Leandro Kasuki et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Association between dopamine and somatostatin receptor expression and pharmacological response to somatostatin analogues in acromegaly
- (2017) Eva Venegas-Moreno et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Somatostatin receptor ligands in the treatment of acromegaly
- (2017) Monica R. Gadelha et al. Pituitary
- Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities
- (2017) Rosario Pivonello et al. Pituitary
- Octreotide and pasireotide (dis)similarly inhibit pituitary tumor cellsin vitro
- (2016) Alejandro Ibáñez-Costa et al. JOURNAL OF ENDOCRINOLOGY
- Combining Cadherin Expression with Molecular Markers Discriminates Invasiveness in Growth Hormone and Prolactin Pituitary Adenomas
- (2016) N. Chauvet et al. JOURNAL OF NEUROENDOCRINOLOGY
- Somatostatin receptor ligands in acromegaly: clinical response and factors predicting resistance
- (2016) Rosa Maria Paragliola et al. Pituitary
- El Registro Molecular de Adenomas Hipofisarios (REMAH): una apuesta de futuro de la Endocrinología española por la medicina individualizada y la investigación traslacional
- (2016) Raúl M. Luque et al. Endocrinologia y Nutricion
- Truncated somatostatin receptor variant sst5TMD4 confers aggressive features (proliferation, invasion and reduced octreotide response) to somatotropinomas
- (2015) Raúl M. Luque et al. CANCER LETTERS
- E-cadherin immunohistochemistry in breast pathology: uses and pitfalls
- (2015) Rita Canas-Marques et al. HISTOPATHOLOGY
- Differential somatostatin receptor (SSTR) 1–5 expression and downstream effectors in histologic subtypes of growth hormone pituitary tumors
- (2015) Katja Kiseljak-Vassiliades et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Interpreting biochemical control response rates with first-generation somatostatin analogues in acromegaly
- (2015) Annamaria Colao et al. Pituitary
- Acromegaly: An Endocrine Society Clinical Practice Guideline
- (2014) Laurence Katznelson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Three Functions of Cadherins in Cell Adhesion
- (2013) Jean-Léon Maître et al. CURRENT BIOLOGY
- Molecular and functional properties of densely and sparsely granulated GH-producing pituitary adenomas
- (2013) Bernhard Mayr et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- A Cellular and Molecular Basis for the Selective Desmopressin-Induced ACTH Release in Cushing Disease Patients: Key Role of AVPR1b Receptor and Potential Therapeutic Implications
- (2013) R. M. Luque et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Expression of SSTR2a, but not of SSTRs 1, 3, or 5 in Somatotroph Adenomas Assessed by Monoclonal Antibodies Was Reduced by Octreotide and Correlated With the Acute and Long-Term Effects of Octreotide
- (2013) Olivera Casar-Borota et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Place of Preoperative Treatment of Acromegaly with Somatostatin Analog on Surgical Outcome: A Systematic Review and Meta-Analysis
- (2013) Francisco Pita-Gutierrez et al. PLoS One
- AIP expression in sporadic somatotropinomas is a predictor of the response to octreotide LAR therapy independent of SSTR2 expression
- (2012) Leandro Kasuki et al. ENDOCRINE-RELATED CANCER
- Immunoreactivity Score Using an Anti-sst2A Receptor Monoclonal Antibody Strongly Predicts the Biochemical Response to Adjuvant Treatment with Somatostatin Analogs in Acromegaly
- (2012) Federico Gatto et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Growth hormone granulation pattern and somatostatin receptor subtype 2A correlate with postoperative somatostatin receptor ligand response in acromegaly: a large single center experience
- (2012) Jessica Brzana et al. Pituitary
- Adenoma granulation pattern correlates with clinical variables and effect of somatostatin analogue treatment in a large series of patients with acromegaly
- (2011) Stine Lyngvi Fougner et al. CLINICAL ENDOCRINOLOGY
- Differential expression of genes related to drug responsiveness between sparsely and densely granulated somatotroph adenomas
- (2011) Masako Kato et al. ENDOCRINE JOURNAL
- Resistance to Somatostatin Analogs in Acromegaly
- (2011) Annamaria Colao et al. ENDOCRINE REVIEWS
- Relationship between cytokeratin staining patterns and clinico-pathological features in somatotropinomae
- (2010) Yuriz Bakhtiar et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- The Expression of E-Cadherin in Somatotroph Pituitary Adenomas Is Related to Tumor Size, Invasiveness, and Somatostatin Analog Response
- (2010) Stine Lyngvi Fougner et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A Consensus on Criteria for Cure of Acromegaly
- (2010) A. Giustina et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- ZAC1 target genes and pituitary tumorigenesis
- (2010) Marily Theodoropoulou et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Nuclear Accumulation of E-Cadherin Correlates with Loss of Cytoplasmic Membrane Staining and Invasion in Pituitary Adenomas
- (2009) Marianne S. Elston et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Nuclear E-cadherin Immunoexpression
- (2008) Runjan Chetty et al. ADVANCES IN ANATOMIC PATHOLOGY
- Clinicopathological Features of Growth Hormone-producing Pituitary Adenomas: Difference among Various Types Defined by Cytokeratin Distribution Pattern Including a Transitional Form
- (2008) Abdulkader Obari et al. ENDOCRINE PATHOLOGY
- Low Levels of Raf Kinase Inhibitory Protein in Growth Hormone-Secreting Pituitary Adenomas Correlate with Poor Response to Octreotide Treatment
- (2008) Stine Lyngvi Fougner et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Selective Loss of Somatostatin Receptor 2 in Octreotide-Resistant Growth Hormone-Secreting Adenomas
- (2008) Ursula Plöckinger et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started